Helixmith Co., Ltd (KOSDAQ:084990)
5,670.00
+80.00 (1.43%)
At close: Mar 20, 2026
Helixmith Market Cap
Helixmith has a market cap or net worth of 261.09 billion as of March 20, 2026. Its market cap has increased by 133.33% in one year.
Market Cap
261.09B
Enterprise Value
178.77B
Revenue
3.74B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,670.00
Market Cap Chart
Since December 29, 2005, Helixmith's market cap has increased from 238.64B to 261.09B, an increase of 9.40%. That is a compound annual growth rate of 0.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 261.09B | -8.84% |
| Dec 30, 2025 | 286.41B | 130.37% |
| Dec 30, 2024 | 124.33B | -51.50% |
| Dec 28, 2023 | 256.37B | -35.45% |
| Dec 29, 2022 | 397.14B | -53.54% |
| Dec 30, 2021 | 854.88B | -3.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BINEX | 400.33B |
| GC Cell | 379.44B |
| JETEMA, | 315.74B |
| Bioneer | 307.66B |
| HLB Therapeutics | 265.79B |
| EASY BIO,Inc. | 238.85B |
| Genexine | 211.94B |
| MedPacto | 198.45B |